View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
Jeeva Informatics Solutions|28 January 2022

Jeeva eCaaS – Remote E-Consent as a Service

Jeeva remote eCaaS is a SaaS-based collaboration platform hosted on the secure AWS-cloud that helps clinical researchers to screen and recruit participants by obtaining proper informed consent remotely. It cuts timelines, maximizes social media outreach to targeted groups, minimizes expensive screen failures, and boosts success rate while ensuring compliance.

Faster. Compliant. Scalable.

Jeeva remote eCaaS is a SaaS-based collaboration platform hosted on the secure AWS-cloud that helps clinical researchers to screen and recruit participants by obtaining proper informed consent remotely. It cuts timelines, maximizes social media outreach to targeted groups, minimizes expensive screen failures, and boosts success rate while ensuring compliance.

Jeeva eConsent as a Service (eCaaS) platform combines:

  • Pre-screen patients on social media and online channels
  • Inform and educate patients about a clinical trial using approved multimedia content
  • Verify patient comprehension using scored quizzes
  • Video/Telemedicine/SMS/Email Communications
  • Bring Your Own Device (BYOD) means no special hardware requirements
  • Compliant Electronic Signatures in adult or pediatric studies

Why Researchers Choose Jeeva eCaaS?

  • To obtain proper electronic informed consent from patients without requiring in-person visits
  • Engage and enroll participants in clinical studies via 4 channel bi-directional communication on your mobile device.
  • 3x-5x faster enrollment with 70% less burden
  • Save significant time and minimize risk of delays by automating repetitive tasks and expanding patient screening, education, and enrollment beyond the 4-walls of the clinical sites,
  • Enterprise license or per-clinical study subscription
  • Pay per study as enrollment scales or license institution-wide. Add-on modules such as ePRO, eCOA, eVisits, & Telemedicine.
  • Ensure continuity & integrity of clinical research
  • The pandemic put breaks on non-critical clinical trials due to travel restrictions and safety concerns in visiting sites in-person. Jeeva is committed to helping restart clinical research.

Testimonials

Jeeva represents the next generation of software platforms with remote touchless eConsent including for pediatric research.” Marshall Summar, MD, Ph.D., Director, Rare Disease Institute, Children’s National Hospital

We enjoyed seamless transition of our cohort study to the Jeeva platform and flexibility in programming. Outstanding live support by JEEVA staff.” Lawrence Cheskin, MD, Ph.D., Professor & Chair, George Mason University

Use Cases for Jeeva eCaaS Include:

  • Patient Registries and Natural History Studies
  • Sponsored Clinical Trials for Biopharma or medical devices
  • Investigator Initiated Trials
  • Biospecimen Collection & Biobanking

eCaaS Compliance & Security

Jeeva empowers clinical studies in the following environments:

  • Good Clinical Practice (GCP)
  • US Food and Drug Administration (FDA) 21 CFR part 11
  • Health Insurance Portability and Accountability Act 1996 (HIPAA)
  • EU General Data Protection Regulation (GDPR)
  • AICPA Service Organisation Control (SOC) 2 Reports
  • Amazon Web Services (AWS) partner network-reviewed

Our Jeeva Clinical cloud-based software provides a seamless solution that improves the experience of investigators and patients by decentralizing clinical trials.
When clinical investigators and study coordinators start planning a new study design in the new normal, speed and efficiency are paramount.
Clinical trials are the regulatory mechanisms agencies like the Food and Drug Administration (FDA) use to evaluate and review evidence of safety and efficacy of...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena